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Q1

Home Dialysis in the Time of COVID-19: Reﬂections
on Rapidly Changing Policies

Q5

Mala Sachdeva, Kenar D. Jhaveri, and Steven Fishbane

O

n March 1, 2020, New York City had its first case of
coronavirus disease 2019 (COVID-19) as a result of
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 New York City and its surrounding
areas of Long Island and Westchester became the epicenters for this rapidly spreading viral infection. Risk factors
for severe illness with COVID-19 were soon found to
include advanced age, diabetes mellitus, hypertension,
chronic kidney disease, heart disease, obesity, and malignancy.2,3 Due to their underlying comorbid conditions, as
well as immunosuppressed status, patients with end-stage
kidney disease (ESKD) were a vulnerable population with
potentially increased susceptibility for this virus.4 Reports
of hospitalized maintenance hemodialysis (HD) patients
having poor outcomes and high mortality emerged across
the United States, China, and Europe.5-8
Outpatient in-center HD and home dialysis centers,
both peritoneal dialysis (PD) and home HD units, immediately began to take appropriate infection control measures to decrease exposure and community spread of
COVID-19. International and national societies recommended best practices in taking care of patients with ESKD
during the COVID-19 pandemic.9-11 The American Society
of Nephrology in conjunction with the Centers for Disease
Control and Prevention established a COVID-19 Response
Team that informed in-center dialysis units of best practices as this pandemic took its course.12,13
We discuss many of the policies and procedures that
were implemented in our outpatient home HD and PD
units to deal with the emerging COVID-19 pandemic.
Our goals included the following: decrease community
risk to our patients and staff, allow patients to stay at
home as much as possible by managing them remotely,
stay abreast of the new and changing statistics in the
region so that care can be tailored accordingly, and
continue to provide quality and safe care to our
patients.
Revised Policies and Procedures
In-Center Visits
In an effort to flatten the curve, New York was issued “stay
at home” orders and residents were advised to practice
“social distancing.” In contrast to patients receiving HD
who dialyze in-center 3 times a week, patients receiving
home HD and PD dialyze at home. This itself makes it
easier to self-isolate; however, these patients often need to
make visits to the outpatient center for blood draws,
administration of medications such as intravenous iron or
erythropoiesis-stimulating agents (ESAs), procedures such

as transfer set changes, and their monthly in-person visit
with the physician.
We immediately cut down the visits for patients to a
maximum of 1 visit per month. During this monthly visit,
they had a quick visit with the registered nurse (RN) and
had their monthly laboratory test specimens drawn. Some
patients receiving PD chose to get their laboratory specimens drawn at a nearby community laboratory, which was
allowable. They were advised to call the laboratory ahead
of time to schedule the laboratory draw, to try to be the
first patient on the schedule to avoid exposure, and to wear
a face mask for their protection. For patients receiving PD
who were clinically stable, at their physician’s discretion
they were exempt from their monthly laboratory draw.
One elderly immunocompromised patient who had difficulty coming to the center was allowed to wait until the
following month for his monthly laboratory specimen to
be drawn. This patient had stable hemoglobin levels over
time and had been receiving a steady ESA dose, which he
was already self-administering. No subsequent adverse
consequences were noted as a result of skipping the
monthly laboratory draw. Careful consideration must be
taken when deciding to continue medications without
monthly laboratory tests. Both the patient’s clinical and
laboratory history and trends should be taken into account
when deciding to skip a laboratory draw for a respective
month. In addition, safely administering medication
without recent laboratory work may not be possible. Patients receiving home HD continued to send in their
monthly laboratory specimens from home directly to their
laboratory.
Patients who were previously receiving ESA injections at
the center were taught to self-inject in an effort to continue
this medication at home and limit their clinic visits. The
decision of whether to teach self-injections was based on
the patient’s ability and adherence history. There was no
hemoglobin threshold that influenced this decision.
Appropriate numbers of vials and syringes were provided
to the patient. Still, some had to come to the dialysis unit
because they could not self-inject or due to their need for
intravenous iron. In those who were receiving multiple
subcutaneous ESA injections and who could not self-inject,
their ESA dosing was changed to the best possible equivalent monthly dosing so that the number of visits to the
clinic were reduced. Home intravenous iron infusions
were avoided due to safety concerns. However, if iron
infusions could be skipped for a particular month they
were because these infusions were not considered emergent. We recommend teaching select patients to self-inject
before a pandemic is expected. Although it is unclear as to

Kidney Med Vol XX | Iss XX | Month 2020
EDI 5.6.0 DTD  XKME208_proof  8 December 2020  12:16 pm  ce

1

57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112

Sachdeva et al

113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168

what the best practice is if a patient has COVID-19,
withholding the ESA dose and/or the intravenous iron
dose may be of benefit.
Scheduled in-center PD visits were purposely spaced to
allot ample time for patients to maintain distance from
other patients and allow time for appropriate disinfection
of the rooms. We were unable to provide separate entrances and exits for HD and PD patients; however, PD
patients were not scheduled at the times when HD shifts
were expected to change, thus allowing more social
distancing and less overlap of patients in the waiting room.
Waiting rooms were set up to maintain social distancing
and were monitored by staff to make sure this was followed. For the most part, visitors were not allowed to
accompany patients to their appointments. Immunosuppressed or elderly were prioritized as the first appointments of the day to decrease their exposure risk. All staff
and patients who entered the dialysis center had temperature screening and were again screened for symptoms by
a designated staff member on arrival. For their visit, PD
patients were seen 1 at a time and there was 1 RN assigned
to 1 patient to minimize exposure risk. Contact with PD
effluent was minimized. However, if handled, the RN used
full universal precautions and all personal protective
equipment (PPE), consistent with previous practice.
Telehealth

In March 2020, the Centers for Medicare & Medicaid
Services encouraged telehealth visits between patients with
ESKD and providers. Since March 1, all our patients were
offered the option of doing telehealth visits, which served
to replace the in-person encounter with the physician.
Patients initially were consented over the telephone;
however, written consents were later obtained when the
patient came for their visit. Written and verbal instructions
were provided to all patients on how to use the telehealth
platform. Telehealth visits were well received by physicians, staff, and patients. All but 5 of 47 patients agreed to
use telehealth. Barriers included either patient preference
(3 patients) or patient inability to accommodate televisits
because they had flip telephones that did not have the
ability to download the application required for the visit
and did not have a camera for the virtual visit (2 patients).
Patients were instructed to check their vital signs and
weight before the televisit. During the visit, limited yet
useful visual examinations were performed, monitoring
the patient’s general appearance and respiratory rate and
effort and observing for edema. Access was visualized
virtually: for the PD patient, we visualized the exit site, and
for the home HD patient, we visualized the vascular access.
Thorough review of systems was performed, looking for
any symptoms of peritonitis or exit-site infections. Patients
were screened for any viral signs, symptoms, or possible
exposure to SARS-CoV-2. For PD patients, flowsheets were
brought by the patient at their RN appointment and then
subsequently uploaded by patients onto the telehealth

2

platform. These were all reviewed at the telehealth visit.
For the home HD patient, flowsheets were faxed or
emailed to the RN on a daily basis, as was usually done.
The RN, physician, dietician, and/or social worker were
present at the monthly telehealth visit from their respective
work spaces, making these visits multidisciplinary.
Monthly laboratory results were reviewed during this visit
and prescriptions were sent electronically to the patient’s
pharmacy. Pharmacies that provided home delivery were
preferred by the patient and physician. Average visits lasted
20 to 30 minutes per patient.
Telehealth visits were also used to perform 30-day, 90day, or yearly interdisciplinary care plan meetings. In
addition, for patients with suspected symptoms or with
other acute issues, televisits were performed to further
assess and triage these active issues. We were able to triage
a patient with peritonitis through telehealth, which
necessitated an immediate in-person visit shortly thereafter
to obtain an effluent cell count and culture.
Education and Triage

All RNs and staff were educated on COVID-19 and its
symptoms. Patients received continued education on how
to recognize and report symptoms of COVID-19. Patients
were contacted within 24 hours of a scheduled visit to
screen for any symptoms of acute viral illness. In addition,
they were questioned on possible exposure, sick contacts,
or recent travel to a high-risk area. If illness was suspected
in any patient, they were encouraged to get tested for
COVID-19 and/or quarantine themselves accordingly.
Symptomatic patients were followed up daily with telephone calls by the RN.
Through telephone triage, we were able to identify 4
patients with possible COVID-19 symptoms. Of these, 2
were tested at an urgent care and were positive for COVID19, one tested negative and likely had another viral illness,
and one was not tested at the discretion of her nephrologist. However, subsequent antibody testing later turned up
positive, confirming our suspicion and rightful suggestion
to quarantine at triage. Similarly, telephone call triage
identified 1 patient who returned from foreign travel from
an endemic area. We successfully quarantined anyone
coming from foreign travel for at least a 14-day period.
There was a designated COVID-19–positive cohort incenter unit in the vicinity where COVID-19–positive
home patients could go; however, we managed not to use
the services of this additional outpatient unit. Patients were
allowed back to the center if they had 2 negative nasopharyngeal swab tests performed after resolution of fever,
without being on antipyretic treatment and if they showed
improvement in their respiratory symptoms. Due to initial
difficulty obtaining 2 swabs, we used a time-based
approach in which patients were allowed to return to the
clinic if they were afebrile for 72 hours without the use of
antipyretics such as acetaminophen, their respiratory
symptoms such as cough or shortness of breath had
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improved, and it had been 14 days since the first symptom
appeared. The medical director and nurse manager decided
on the appropriate return of these patients to the center.
Similarly, staff were to report any developing acute
symptoms. Staff who were not feeling well were advised to
stay home until symptoms resolved or they were tested.
They were discouraged from foreign travel.

soon changed to allow select patients who were not
COVID-19 positive and who needed assistance carrying
supplies into their home to be assisted by the delivery
service as long as social distancing was upheld. For the
most part, the timely delivery of PD or home HD supplies
seemed uninterrupted.
Surgical Procedures

Procedures

Only essential procedures were performed during patient
visits. Nonessential procedures such as transfer set changes
were postponed unless urgent. To minimize patient time
in the center, peritoneal equilibration testing was postponed because this requires the patient to be in the PD unit
for more than 4 hours.
New Trainings

New PD trainings were suspended in March 2020 for a
brief period during the height of the pandemic to decrease
prolonged patient-RN contact. However, due to the
accumulating demand for training, it was restarted within
4 weeks. One patient was in training at the time of the
pandemic and this training was continued. New home HD
trainings were postponed due to prolonged contact time
and number of days of training required. No new training
was performed virtually. We suspended any acceptance of
foreign admissions for a brief period.
Home Visits

Physical home visits were avoided. New patient home
visits and postperitonitis home visits were successfully
performed through televisits.
Staff

No shortages in staff were noted. RNs were rotated so that
if they had no patient visits scheduled they were able to
work from home.
Staff Meetings

Monthly quality meetings were done with teleservices over
a webinar platform called WebEx and/or telephone.
Likewise, weekly core team meetings were performed in
the same way.
Personal Protective Equipment

Appropriate use of PPE was taught to staff. All staff wore
surgical masks and/or N95 masks, face shields, hair caps,
disposable gowns, and gloves when encountering a patient. All patients were provided surgical masks. Patients
were not allowed to bring an additional person to the
center with them unless absolutely necessary. Neither patients nor staff had a shortage of surgical masks.
Delivery of PD Supplies

In early April, home dialysis supply companies in New
York left home supplies outside patients’ homes. This was

Elective nonurgent surgeries were cancelled during the
pandemic. At our institution, PD catheter placements were
not considered elective procedures because they were
necessary to initiate PD. We found that many patients who
were scheduled for this procedure cancelled it themselves
due to personal fear, and that at times the surgeon involved
in catheter placement was deployed to work in the hospital
and hence was not immediately available. As a consequence of these postponements, we later noted a surge of
patients who needed to be trained for PD and home HD
when the pandemic reached low numbers. New arteriovenous fistula or graft creations were postponed during the
pandemic. HD catheter placements were allowed if
emergent. Other access procedures such as declotting were
done on a case-by-case basis.
Our Experience
Collectively from March to June 2020, of our 47 patients
receiving long-term PD, 5 developed COVID-19 illness.
Four were symptomatic, 2 of whom were hospitalized,
and 1 was asymptomatic. None of the 6 patients in our
home HD program contracted the virus or had symptoms
of COVID-19. We were able to screen all 4 symptomatic
PD patients appropriately with the described measures of
triage using telephone and telehealth capabilities. One PD
patient was asymptomatic; however, antibody testing later
was positive. A total of 89% of our PD patients agreed to
remote televisits and all our home HD patients agreed.
After about 3 to 4 months, when the pandemic reached
low numbers, telehealth visits were switched back to
in-person visits with appropriate use of PPE by staff and
patients. Patients, RNs, and physicians welcomed the faceto-face visit, and there was no hesitancy in the switch. No
one expressed preference of one visit type over the other,
however, should the pandemic numbers increase again,
staff and patients are prepared to switch back to telehealth
visits. The virtual visit seemed to be a good substitute of
the in-person visit in the setting of necessity, however,
most of our physicians, RNs, and patients prefer the faceto-face encounter.
We have learned that during a pandemic, outpatient
home dialysis centers must be quick to adopt new policies
and procedures and must be ready to change on a daily
basis as the course of the pandemic changes. With our
home dialysis units in the epicenter of the pandemic, we
were able to successfully manage our patients remotely as
much as possible with a low number of incident COVID19 cases. To date, no staff member has become ill, due
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Box 1. Changes Implemented in the Home Dialysis Program

Pre–COVID-19
Multiple in-center visits
In-person monthly face-to-face encounter with
physician
ESA injections
Intravenous iron administration
Monthly laboratory draw
Timing of dialysis unit visit scheduled
according to patient convenience
PPE used depending on situation
Transfer set changes
PET testing
In-person visits

Home visits for new patients
In-person staff meetings
All staff present at the dialysis unit
Monthly patient education

Changes Implemented During the Pandemic
Decrease number of in-center visits with a goal of 1 visit/mo
Use telehealth to replace the in-person physician encounter
Select patients taught to self-inject; others who had multiple injections were
changed to equivalent monthly dosing
Continued or withheld depending on necessity
Potential to skip if history and laboratory trends had been stable
Patient visits were spaced; visits were scheduled around HD shift changes to
avoid crowding in the waiting room; elderly and immunocompromised patients
were given earlier appointments; all patients received temperature and symptom
screening on arrival; all staff and patients wore appropriate PPE
PPE mandatory for staff and patients
Postponed unless urgent
Postponed to avoid contact with dialysate and time patient spent in the dialysis
unit
Telehealth used for:
- Monthly face-to-face physician encounter
- Triage for acute issues
- Interdisciplinary team meetings
- Screening for symptoms via telephone triage
Home visits were converted to virtual visits
Monthly quality meetings and weekly core team meetings changed to virtual
Those with no patient responsibilities were allowed to work from home
Educate patients on signs, symptoms, reporting of the illness, and good hygiene
during telephone calls to patient and in-person visit with RN

Abbreviations: COVID-19, coronavirus disease 2019; ESA, erythropoiesis-stimulating agent; HD, hemodialysis; PET, peritoneal equilibration testing; PPE,
personal protective equipment; RN, registered nurse.

to PPE use, education, and the policies that were implemented. We recommend having full discussions and plans
in place before a pandemic hits an area and discussing
potential changes ahead of time with patients and staff,
especially the potential need for televisits and the specifics
required, including obtaining consents and downloading
the applications needed for the visit. Box 1 summarizes the
changes made in the home dialysis unit at the time of the
pandemic.
This pandemic has affected the ESKD population, with
high mortality rates being reported among patients
receiving HD. Although data for hospitalized patients
receiving HD are emerging, 1 large study reported that of
419 hospitalized patients with ESKD, 11 (2.6%) receiving
long-term PD were hospitalized.8,14,15 Our hospitalization
rate for our COVID-19–infected patients was 4.3% in PD
patients (2 of 47) and zero in home HD patients, while our
outpatient in-center HD units had hospitalization rates of
5% (4 of 80, with no deaths), 11% (17 of 156 patients,
with 6 deaths), and 15% (27 of 178 patients, with 7
deaths). This smaller number of inpatient PD and home
HD hospitalizations, together with our low number of
outpatients receiving PD and home HD who tested positive
for COVID-19, perhaps points to the protective effect of
home therapies.8,14 Although more needs to be studied
4

comparing PD with HD in the outpatient setting, we
believe that patients receiving PD or home HD are at an
advantage in this pandemic or any other due to their ability
to dialyze at home, among other reasons. We also noted an
increase in the interest in home therapies in both patients
with chronic kidney disease and those with ESKD receiving
HD as a consequence of the pandemic, which needs to be
examined further.
During the COVID-19 pandemic, there was an effort
made to treat patients at home. Safety was established
from several sites in the United States, suggesting that
home dialysis might be advantageous during a
pandemic.16 In addition, shortages in supplies, staffing,
and available equipment for HD and a continuous form of
renal replacement therapy among critically ill patients
with COVID-19, particularly in the New York City area,
have demanded implementation of alternative strategies
such as acute PD treatment for acute kidney injury.17
Given the interest in acute PD and the increased safety
of long-term PD and home HD, the nephrology community has an opportunity to further embrace home
modalities. We urge all training programs and community nephrologists to examine this in their practice and to
promote and increase the transition to home modalities
for our patients.
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